Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment
- Resource Type
- Article
- Source
- In
Cancer Letters 1 October 2016 380(2):494-504 - Subject
- Language
- ISSN
- 0304-3835